Cardioembolic stroke in patients with patent foramen ovale and implanted cardiac leads

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 1, 2013, Pages 50-54

  Desimone, Christopher V ^a   Desimone, Daniel C ^a   Hagler, Donald J ^a   Friedman, Paul A ^a   Asirvatham, Samuel J ^a  

^a MAYO CLINIC   (United States)

Author keywords

cardioembolism; ICD; leads; pacemaker; paradoxical; patent foramen ovale; PFO; Stroke

Indexed keywords

HEPARIN; VANCOMYCIN; WARFARIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACTEREMIA; CARDIAC IMPLANT; CARDIAC LEAD IMPLANT; CARDIOEMBOLIC STROKE; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DEVICE REMOVAL; FEMALE; FEVER; HEART VENTRICLE TACHYCARDIA; HEMIPARESIS; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MEDICAL DEVICE COMPLICATION; PATENT FORAMEN OVALE; SLURRED SPEECH; THROMBOEMBOLISM; URINARY TRACT INFECTION; VENTRICULAR PACEMAKER; WEAKNESS;

ADULT; AGED; CORONARY THROMBOSIS; DEVICE REMOVAL; ELECTRODES, IMPLANTED; FEMALE; FORAMEN OVALE, PATENT; HUMANS; MALE; MIDDLE AGED; STROKE; TREATMENT OUTCOME;

EID: 84872179451     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12014     Document Type: Article

References (13)

1. Asirvatham SJ,. Implantation of cardiac resynchronization devices. In:, St. John Sutton M, Bax J, Jessup M, Brugada J, Schalij MJ, (eds.): Cardiac Resynchronization Therapy. London, Informa Healthcare, 2007.
2. Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, Greenspon AJ,. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006. Pacing Clin Electrophysiol 2010; 33: 705-711.
3. Asirvatham SJ, et al. Clinical significance of debris on pacemaker leads detected by transesophageal echocardiography (abstract). Europace 2000; 1: D239.
4. Supple GE, Ren JF, Zado ES, Marchlinski FE,. Mobile thrombus on device leads in patients undergoing ablation: Identification, incidence, location, and association with increased pulmonary artery systolic pressure. Circulation 2011; 124: 772-778.
5. Homma S, Di Tullio MR,. Patent foramen ovale and stroke. J Cardiol 2010; 56: 134-141.
6. McLeod CJ, Attenhofer Jost CH, Warnes CA, Hodge D 2nd, Hyberger L, Connolly HM, Asirvatham SJ, et al. Epicardial versus endocardial permanent pacing in adults with congenital heart disease. J Interv Card Electrophysiol 2010; 28: 235-243.
7. Lau EW,. Achieving permanent left ventricular pacing-options and choice. Pacing Clin Electrophysiol 2009; 32: 1466-1477.
8. Bordachar P, Derval N, Ploux S, Garrigue S, Ritter P, Haissaguerre M, JaÏs P., Left ventricular endocardial stimulation for severe heart failure. J Am Coll Cardiol 2010; 56: 747-753.
9. Rickard J, Wilkoff BL,. Extraction of implantable cardiac electronic devices. Curr Cardiol Rep 2011; 13: 407-414.
10. Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, et al. Study design of the CLOSURE I Trial: A prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke 2010; 41: 2872-2883.
11. Wahl A, Jüni P, Mono ML, Kalesan B, Praz F, Geister L, Räber L, et al. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation 2012; 125: 803-812.
12. Calvert PA, Rana BS, Kydd AC, Shapiro LM,. Patent foramen ovale: Anatomy, outcomes, and closure. Nat Rev Cardiol 2011; 8: 148-160.
13. Agnelli D, Ferrari A, Saltafossi D, Falcone C., A cardiac embolic stroke due to malposition of the pacemaker lead in the left ventricle. A case report. Ital Heart J Suppl 2000; 1: 122-125.